Vol 54, No 1 (2020)
Research Paper
Published online: 2020-01-22

open access

Page views 1606
Article views/downloads 1379
Get Citation

Connect on Social Media

Connect on Social Media

Cerebral venous and sinus thrombosis diagnosis: preliminary study of clinical picture and D-dimer concentration correlation

Izabela Domitrz1, Artur Sadowski1, Wojciech Domitrz2, Jan Kochanowski1
Pubmed: 31965561
Neurol Neurochir Pol 2020;54(1):66-72.

Abstract

Aim of the study. We investigated whether D-dimer (DD) concentration is elevated in cerebral venous and sinus thrombosis (CVST), as has been reported in the literature. Clinical rationale for the study. CVST is a disease with variable clinical presentations and a challenging diagnosis. We looked into whether D-dimer concentration might be an indicator of CVST, and the need for neuroimaging tests correlated with clinical factors. Materials and methods. We included all consecutive patients (mean age 41.6 years) with CVST treated in our neurology department from 2014 to 2018 whose DD levels had been measured. DD concentrations were categorised as normal (≤ 0.5 μg/ml) or elevated ( > 0.5 μg/ml). Appropriate imaging confirmed the diagnosis of CVST. The results were compared to those of a control group consisting of 22 age- and sex-matched patients (mean age 40 years) with a diagnosis of primary headache (tension type or migraine) hospitalised to exclude secondary causes. Results. In 20 patients in the CVST study group, median level of DD was 1.0 + 0.57 μg/ml (range 0.19–2.45 μg/ml), compared to the control group’s mean DD level of 0.50 + 0.45 μg/ml (range 0.15–1.73 μg/ml), with p < 0.005. Higher DD levels were associated with complications of the disease and fatal course (p < 0.005). One female and one male patient died because of CVST with DD levels of (respectively) 2.45 and 1.80 μg/ml — the two highest concentrations in our study group. Conclusions and clinical implications. DD concentration, especially in headache patients, may be a factor to predict CVST and an indicator for further diagnostic procedures with venography. But in clinical practice, low levels of DD cannot be taken to exclude CVST.

Article available in PDF format

View PDF Download PDF file

References

  1. Hinnell C, Nadeau J, Lam V, et al. Sex differences in adult cerebral venous sinus thrombosis: a 10-year experience. Can J Neurol Sci. 2012; 39(1): 74–77.
  2. Park JK, Koo DoH, Yoon DH, et al. D-Dimer Levels and Vitamin K Antagonist Therapy in Deep Vein Thrombosis of the Legs. Ann Vasc Surg. 2016; 34: 119–134.
  3. Cushman M, Folsom AR, Wang Lu, et al. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood. 2003; 101(4): 1243–1248.
  4. Skoro-Sajer N, Gerges C, Gerges M, et al. Usefulness of thrombosis and inflammation biomarkers in chronic thromboembolic pulmonary hypertension-sampling plasma and surgical specimens. J Heart Lung Transplant. 2018; 37(9): 1067–1074.
  5. Takach Lapner S, Stevens SM, Woller SC, et al. Age-adjusted versus clinical probability-adjusted D-dimer to exclude pulmonary embolism. Thromb Res. 2018; 167: 15–19.
  6. Singer AJ, Zheng H, Francis S, et al. D-dimer levels in VTE patients with distal and proximal clots. Am J Emerg Med. 2019; 37(1): 33–37.
  7. Cushman M, Folsom AR, Wang Lu, et al. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood. 2003; 101(4): 1243–1248.
  8. Kuwashiro T, Toyoda K, Oyama N, et al. High plasma D-dimer is a marker of deep vein thrombosis in acute stroke. J Stroke Cerebrovasc Dis. 2012; 21(3): 205–209.
  9. Wang HF, Pu CQ, Yin Xi, et al. D-dimers (DD) in CVST. Int J Neurosci. 2017; 127(6): 524–530.
  10. Zuurbier SM, Hiltunen S, Lindgren E, et al. D-dimer and clinicoradiologic features in cerebral venous thrombosis. J Neurol Sci. 2013; 327(1-2): 12–14.
  11. Misra UK, Kalita J, Bansal V. D-dimer is useful in the diagnosis of cortical venous sinus thrombosis. Neurol India. 2009; 57(1): 50–54.
  12. Meng R, Wang X, Hussain M, et al. Evaluation of plasma D-dimer plus fibrinogen in predicting acute CVST. Int J Stroke. 2014; 9(2): 166–173.
  13. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005; 352: 1791–1798.
  14. Filippidis A, Kapsalaki E, Patramani G, et al. Cerebral venous sinus thrombosis: review of the demographics, pathophysiology, current diagnosis, and treatment. Neurosurg Focus. 2009; 27(5): E3.
  15. Ferro JM, Canha P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of international study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke. 2004; 35: 664–670.
  16. Gameiro J, Ferro JM, Canhão P, et al. International Study on Cerebral Vein and Dural Sinus Thrombosis investigators. Prognosis of cerebral vein thrombosis presenting as isolated headache: early vs. late diagnosis. Cephalalgia. 2012; 32(5): 407–412.
  17. Meng R, Dornbos D, Meng Lu, et al. Clinical differences between acute CVST and non-thrombotic CVSS. Clin Neurol Neurosurg. 2012; 114(9): 1257–1262.
  18. Gunes HN, Cokal BG, Guler SK, et al. Clinical associations, biological risk factors and outcomes of cerebral venous sinus thrombosis. J Int Med Res. 2016; 44(6): 1454–1461.
  19. Wasay M, Kojan S, Dai AI, et al. Headache in Cerebral Venous Thrombosis: incidence, pattern and location in 200 consecutive patients. J Headache Pain. 2010; 11(2): 137–139.